Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients
Clinical trial NCT02845297 · COMPLETED
Trial details
- NCT number
- NCT02845297
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2022-04-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.